Accueil / Tag Archives: Other Health

Tag Archives: Other Health

InDevR Launches Next-Generation Software for the Cypher One™ System

Tuesday, March 21st 2017 at 10:00am UTC Next Generation Cypher One™ Software Increases Functionality and Ensures Data Integrity for the Standardization of Hemagglutination and Hemagglutination Inhibition Assays BOULDER, Colo.–(BUSINESS WIRE)– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, today announced the global launch of …

Plus »

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jersey’s Cooper Neurological Institute

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord …

Plus »

22nd Century Group Issues Annual Letter to Shareholders

Tuesday, March 21st 2017 at 1:50pm UTC Company believes major licensing contract or strategic partnership could generate hundreds of millions of dollars in annual revenue CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced …

Plus »

Teewinot Life Sciences and Noramco Sign Letter of Intent to Produce Cannabinoids with Cannsynthesis™ Biocatalysis Technology

Monday, March 20th 2017 at 2:05pm UTC TAMPA, Fla. & WILMINGTON, Del.–(BUSINESS WIRE)– Teewinot Life Sciences (Teewinot), the market leader in biocatalytic technologies for the production of pharmaceutical-grade cannabinoids, and Noramco, a global leading producer of controlled-substance active pharmaceutical ingredients (APIs), today signed a letter of intent to enter the …

Plus »

NantKwest Announces FDA Grant of Orphan Drug Designation for the Company’s aNK Natural Killer Cell Therapy in Merkel Cell Carcinoma

Monday, March 20th 2017 at 11:00am UTC CULVER CITY, Calif.–(BUSINESS WIRE)– NantKwest, Inc. (Nasdaq:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases, announced today that the FDA has …

Plus »

X-Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple Therapeutic Areas

Monday, March 20th 2017 at 12:15pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, announced the signing of a broad drug discovery collaboration with Astellas Pharma Inc. (Astellas). The collaboration will enable …

Plus »

Pierre Fabre and H-Immune Announce Strategic Research Partnership to Develop Potentially Ground-Breaking Cancer Immunotherapies

Tuesday, March 21st 2017 at 10:00am UTC Pierre Fabre Fund for Innovation will collaborate with H-Immune to utilize In Vitro Immunization (IVI) platform for the development of fully human monoclonal antibody candidates without immunogenic side effects due to humanization Focus on solid tumors provides range of possible cancer indications as …

Plus »

Endocrine Disrupting Chemicals Identified Using xCELLigence® Real-Time Cell Analysis

Monday, March 20th 2017 at 9:00am UTC ACEA Biosciences develops novel assay for the rapid and facile detection of agonists and antagonists of key endocrine receptors SAN DIEGO–(BUSINESS WIRE)– Endocrine-disrupting chemicals (EDCs) are substances that interfere with the ability of endogenous hormones to regulate homeostasis via their cognate nuclear receptors. …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...